|
1.
|
原著(症例報告除く)
|
Association Between Oral Function and Obstructive Sleep Apnea in Elderly Patients: A Cross-Sectional Study Using Home Sleep Apnea Testing. 2026/08
|
|
2.
|
原著(症例報告除く)
|
Imaging-based stratification of marginal versus segmental mandibulectomy in MRONJ. 2026/07
|
|
3.
|
症例報告
|
Incidental Mandibular FDG Uptake on PET/CT Preceding Medication-Related Osteonecrosis of the Jaw in a Patient Receiving High-Dose Denosumab: A Case Report. 2026/07
|
|
4.
|
症例報告
|
Restoration of Trumpet-Playing Ability using a Maxillofacial Prosthesis and External Pressure Support in a Patient with a Maxillary Defect: A Case Report 2026/02
|
|
5.
|
原著(症例報告除く)
|
Prevention of medication-related osteonecrosis of the jaw after tooth extraction by local administration of antibiotics and atelocollagen sponge: A preliminary study 2026/01
|
|
6.
|
症例報告
|
Replantation of a Permanent Tooth With a Curved Root From Infected Tooth Germ: A Case Report With a Four-Year Follow-Up 2024/11
|
|
7.
|
原著(症例報告除く)
|
Postoperative Recurrence of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study of 150 Patients Undergoing Surgery 2024/06
|
|
8.
|
原著(症例報告除く)
|
Pathogenesis of Medication-Related Osteonecrosis of the Jaw: Odontogenic Infection-Preceding Type and Osteonecrosis-Preceding Type 2024/05
|
|
9.
|
原著(症例報告除く)
|
CD69 Signaling in Eosinophils Induces IL-10 Production and Apoptosis via the Erk1/2 and JNK Pathways, Respectively 2024/03
|
|
10.
|
原著(症例報告除く)
|
Medication-related osteonecrosis of the lower jaw without osteolysis on computed tomography images. 2024/01
|
|
11.
|
症例報告
|
Postoperative hemorrhage after Le Fort Ⅰ osteotomy hemoostasis with angiographic embolization: report of two cases 2023/12
|
|
12.
|
症例報告
|
Postoperative hemorrhage after Le Fort I osteotomy hemostasis with angiographic embolization: report of two cases 2023/12
|
|
13.
|
原著(症例報告除く)
|
Drug holiday of high-dose denosumab and recovery from osteoclast inhibition using immunohistochemical investigation of 7 patients with medication-related osteonecrosis of the jaw undergoing segmental mandibulectomy. 2023/10
|
|
14.
|
症例報告
|
Adenoid ameloblastoma with BRAF p.V600E mutation revealing ameloblastomatous origin: a first case report 2023/09
|
|
15.
|
原著(症例報告除く)
|
Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study 2023/08
|
|
16.
|
症例報告
|
新規subtypeとみなされるBRAF mutationが検出されたadenoid ameloblastomaの一例 2023/03
|
|
17.
|
原著(症例報告除く)
|
Factors Exacerbating Clinical Symptoms and CT Findings in Patients with Medication-Related Osteonecrosis of the Jaw Receiving Conservative Therapy: A Multicenter Retrospective Study of 53 Cases 2022/06
|
|
18.
|
その他
|
医科大学附属病院における顎顔面補綴治療の問題点と展望 2022/06
|
|
19.
|
原著(症例報告除く)
|
Relationship between Drug Holidays of Antiresorptive Agents and Surgical Outcomes in Cancer Patients with Medication-Related Osteonecrosis of the Jaw 2022/04
|
|
20.
|
症例報告
|
Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report 2022/01
|
|
21.
|
症例報告
|
再発を繰り返す鼻腔癌患者の上顎顎欠損に対する顎義歯を製作した一症例 2021/12
|
|
22.
|
原著(症例報告除く)
|
Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy 2021/11
|
|
23.
|
原著(症例報告除く)
|
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients 2021/08
|
|
24.
|
原著(症例報告除く)
|
Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study 2021/07
|
|
25.
|
原著(症例報告除く)
|
Treatment and outcome of maxillary sinusitis associated with maxillary medication-related osteonecrosis 2021/07
|
|
26.
|
原著(症例報告除く)
|
Corrigendum to "The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions" [Allergol Int 70 (2021) 9-18] 2021/04
|
|
27.
|
原著(症例報告除く)
|
Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery 2021/03
|
|
28.
|
原著(症例報告除く)
|
Odontogenic maxillary sinusitis: therapeutic management of cases with oroantral fistulae 2021/03
|
|
29.
|
原著(症例報告除く)
|
Combination therapy with lenvatinib and radiation significantly inhibits thyroid cancer growth by uptake of tyrosine kinase inhibitor 2021/01
|
|
30.
|
総説
|
The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions 2021/01
|
|
31.
|
原著(症例報告除く)
|
Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery 2020/12
|
|
32.
|
原著(症例報告除く)
|
好酸球性副鼻腔炎鼻茸組織中好酸球おけるCD69分子の発現と機能 2020/06
|
|
33.
|
原著(症例報告除く)
|
甲状腺癌細胞株に対する放射線療法とレンバチニブの相乗効果 2020/06
|
|
34.
|
原著(症例報告除く)
|
慢性炎症の原因除去と免疫若返りによる老人性難聴予防 2020/06
|
|
35.
|
原著(症例報告除く)
|
Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings. 2020/04
|
|
36.
|
原著(症例報告除く)
|
Reduced local response to corticosteroids in eosinophilic chronic rhinosinusitis with asthma 2020/02
|
|
37.
|
原著(症例報告除く)
|
Multiple biological aspects of eosinophils in host defense, eosinophil-associated diseases, immunoregulation, and homeostasis: is their role beneficial, detrimental, regulator, or bystander? 2020
|
|
38.
|
原著(症例報告除く)
|
Periosteal reaction as a risk factor for poor outcomes after surgical treatment for medication-related osteonecrosis of the jaw: A retrospective analysis of 205 surgeries. 2020
|
|
39.
|
原著(症例報告除く)
|
Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. 2019/09
|
|
40.
|
原著(症例報告除く)
|
80歳以上高齢者における薬剤関連顎骨壊死の治療と予後 2019/06
|
|
41.
|
原著(症例報告除く)
|
A novel approach for investigating upper airway hyperresponsiveness using micro-CT in eosinophilic upper airway inflammation such as allergic rhinitis model. 2019/06
|
|
42.
|
原著(症例報告除く)
|
Eosinophilic upper airway inflammation in a murine model using an adoptive transfer system induces hyposmia and epithelial layer injury with convex lesions 2019/02
|
|
43.
|
原著(症例報告除く)
|
A comparison of short-term outcomes of neck dissection for head and neck cancers using thunderbeatTM, LigaSureTM or treatment without an energy-based device: a case controlled study. 2018/10
|
|
44.
|
原著(症例報告除く)
|
薬剤関連顎骨壊死(MRONJ)の治療法と予後に関する臨床的研究 保存療法と外科療法の比較検討 2018/02
|
|
45.
|
原著(症例報告除く)
|
再発転移頭頸部扁平上皮癌に対するセツキシマブ併用化学療法後の治療効果および予後因子の検討 2017/12
|
|
46.
|
原著(症例報告除く)
|
Enhancement of anti-inflammatory and osteogenic abilities of mesenchymal stem cells via cell-to-cell adhesion to periodontal ligament-derived fibroblasts 2017/01
|
|
47.
|
その他
|
VEGF-C and TGF-beta reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes 2016/04
|
|
48.
|
原著(症例報告除く)
|
Establishment of mesenchymal stem cell lines derived from the bone marrow of green fluorescent protein‑transgenic mice exhibiting a diversity in intracellular transforming growth factor‑β and bone morphogenetic protein signaling 2016/03
|
|
49.
|
原著(症例報告除く)
|
義歯装着のためのスペースの狭小化に対応した下顎顎義歯の1例 2015/12
|
|
50.
|
その他
|
歯肉の口腔粘膜疾患 2015/04
|
|
51.
|
原著(症例報告除く)
|
PDGF-induced PI3K-mediated signaling enhances the TGF-β-induced osteogenic differentiation of human mesenchymal stem cells in a TGF-β-activated MEK-dependent manner. 2014/03
|
|
52.
|
原著(症例報告除く)
|
Novel SCRG1/BST1 axis regulates self-renewal, migration, and osteogenic differentiation potential in mesenchymal stem cells. 2014/01
|
|
5件表示
|
|
全件表示(52件)
|